Oncology
Atezolizumab Approved for Stage III dMMR Colon Cancer
The FDA approved adjuvant atezolizumab plus chemotherapy after resection of stage III dMMR colon cancer in adults and patients aged 12 years or older. The subcutaneous formulation is limited to adults.
Rayan Salih · November 11, 2026 · 6 min